AR025224A1 - Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma - Google Patents

Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma

Info

Publication number
AR025224A1
AR025224A1 ARP000104160A ARP000104160A AR025224A1 AR 025224 A1 AR025224 A1 AR 025224A1 AR P000104160 A ARP000104160 A AR P000104160A AR P000104160 A ARP000104160 A AR P000104160A AR 025224 A1 AR025224 A1 AR 025224A1
Authority
AR
Argentina
Prior art keywords
oxazolidinona
guanidina
amida
methods
same
Prior art date
Application number
ARP000104160A
Other languages
English (en)
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of AR025224A1 publication Critical patent/AR025224A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

Compuestos de amidina y guanidina oxazolidinona N-sustituidos que tienen la formula (1) en la cual los sustituyentes tienen los siguientes significadosindicados en la descripcion. Estos compuestos son utiles como agentes antibacterianos.
ARP000104160A 1999-08-12 2000-08-11 Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma AR025224A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14846999P 1999-08-12 1999-08-12
US09/621,819 US6297242B1 (en) 1999-08-12 2000-07-21 N-substituted amidine and guanidine oxazolidinone antibacterials and methods of use thereof

Publications (1)

Publication Number Publication Date
AR025224A1 true AR025224A1 (es) 2002-11-13

Family

ID=22525916

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104160A AR025224A1 (es) 1999-08-12 2000-08-11 Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma

Country Status (4)

Country Link
US (1) US6297242B1 (es)
AR (1) AR025224A1 (es)
AU (1) AU6892900A (es)
WO (1) WO2001042229A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7179912B2 (en) * 2000-09-01 2007-02-20 Icos Corporation Materials and methods to potentiate cancer treatment
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
PL1656370T3 (pl) 2003-06-03 2013-03-29 Melinta Subsidiary Corp Biarylowe związki heterocykliczne oraz sposoby ich wytwarzania i stosowania
TW200526649A (en) * 2003-12-17 2005-08-16 Rib X Pharmaceuticals Inc Halogenated biaryl heterocyclic compounds and methods of making and using the same
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス，インコーポレイテッド トリアゾール類の合成方法
DE602006010702D1 (de) 2005-06-29 2010-01-07 Pharmacia & Upjohn Co Llc Homomorpholinoxazolidinone als antibakterielle mittel
US20110038809A1 (en) 2005-11-01 2011-02-17 Perl Daniel P Growth control of oral and superficial microorganisms using gallium compounds
US8895077B2 (en) * 2007-04-02 2014-11-25 Mount Sinai School Of Medicine Methods for preventing or treating infectious diseases caused by extracellular microorganisms, including antimicrobial-resistant strains thereof, using gallium compounds
US8507640B2 (en) 2010-08-19 2013-08-13 International Business Machines Corporation Methods of ring opening polymerization and catalysts therefor
WO2018170664A1 (en) * 2017-03-20 2018-09-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES533097A0 (es) * 1983-06-07 1985-08-01 Du Pont Un procedimiento para la preparacion de nuevos derivados del amino-metil-oxooxazolidinil-benzeno.
DE69216251T2 (de) 1991-11-01 1997-05-15 Pharmacia & Upjohn Co., Kalamazoo, Mich. Substituierte aryl- und heteroaryl-phenyloxazolidinone
MY115155A (en) 1993-09-09 2003-04-30 Upjohn Co Substituted oxazine and thiazine oxazolidinone antimicrobials.
US6124334A (en) 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
CN1075073C (zh) 1995-02-03 2001-11-21 法玛西雅厄普约翰美国公司 杂芳环取代的苯基噁唑烷酮抗菌剂
ES2162047T3 (es) 1995-05-11 2001-12-16 Upjohn Co Oxazolidinonas con resto diazinilo y carbazinilo espirociclico y biciclico.
US5883093A (en) 1995-09-12 1999-03-16 Pharmacia & Upjohn Company Phenyloxazolidinone antimicrobials
DE19601264A1 (de) 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
DE19604223A1 (de) 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
KR100530297B1 (ko) 1996-04-11 2005-11-22 파마시아 앤드 업존 캄파니 엘엘씨 옥사졸리디논의 제조 방법
SK156499A3 (en) 1997-05-30 2000-06-12 Upjohn Co Oxazolidinone antibacterial agents having a thiocarbonyl functionality
EP0994874A1 (en) * 1997-07-11 2000-04-26 PHARMACIA & UPJOHN COMPANY Thiadiazolyl and oxadiazolyl phenyl oxazolidinone antibacterial agents
WO1999012914A1 (fr) * 1997-09-11 1999-03-18 Hokuriku Seiyaku Co., Ltd. Derives de thiouree
CA2315735A1 (en) * 1998-02-13 1999-08-19 Michael R. Barbachyn Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
JPH11322729A (ja) 1998-03-09 1999-11-24 Hokuriku Seiyaku Co Ltd ジチオカルバミド酸誘導体
WO2000029396A1 (de) * 1998-11-17 2000-05-25 Bayer Aktiengesellschaft Neue substituierte phenyloxazolidon-derivate
CA2351062A1 (en) * 1998-11-27 2000-06-08 Pharmacia & Upjohn Company Oxazolidinone antibacterial agents having a thiocarbonyl functionality

Also Published As

Publication number Publication date
AU6892900A (en) 2001-06-18
US6297242B1 (en) 2001-10-02
WO2001042229A1 (en) 2001-06-14

Similar Documents

Publication Publication Date Title
ES2193508T3 (es) Ftalizinonas.
UY34152A (es) ?oxazolidinonas substituidas y su uso?.
NL350077I1 (nl) Cyprosulfamide
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
AR023727A1 (es) Compuestos empleados en el tratamiento de padecimientos inflamatorios
DK1093819T3 (da) Forbindelse og præparat til tilförsel af aktive midler
EA200300050A1 (ru) Гликопептидфосфонатные производные
AR010062A1 (es) Nuevos benzamidaldehidos y su utilizacion
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
DE69716925D1 (de) Isoxazoline derivate und ihre verwendung als antimikroben
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
PT998460E (pt) Novos derivados de tetrazole
BR9711586A (pt) Compostos e uso dos mesmo
PT1086096E (pt) Benzamidas com substituintes etra-hidrofuraniloxi como inibidores da fosfodiesterase 4
AR025224A1 (es) Amida y guanidina oxazolidinona n-sustituida antibacteriana y metodos de uso de la misma
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
PT1089625E (pt) Agentes ectoparasiticidas
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
DE60121587D1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
ATE259813T1 (de) Triazolopyrimidinderivate
ECSP044971A (es) Isoxazolopiridinonas y su uso en el tratamiento de enfermedad de parkinson
ATE320422T1 (de) Metalloproteinase inhibitoren
DE69936052D1 (de) N1 modifizierte glycopeptide

Legal Events

Date Code Title Description
FB Suspension of granting procedure